Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms, Basal Cell × Erlotinib Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Papillary renal cell carcinoma, sporadic 1 Pancreatic Neoplasms 1 Neoplasms, Basal Cell 1 Neoplasms 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Hereditary leiomyomatosis and renal cell cancer 1 Carcinoma, Renal Cell 1

Interventions

folfirinox 1 Taxes 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Gemcitabine 1 Fluorouracil 1 Erlotinib Hydrochloride 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06483555 2025-04-16

PANGEA

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting

DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡